HOME › DRUGS › BRODALUMAB
ACTIVE SUBSTANCE / INN

BRODALUMAB

Brand name(s): Kyntheum, SILIQ
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Psoriasis
BLA761032
ACTIVE SUBSTANCE
Brodalumab
REGULATORS
FDA · EMA
SPONSORS / MAH
VALEANT LUXEMBOURG, LEO Pharma A/S
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SILIQBLA761032VALEANT LUXEMBOURGPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
KyntheumLEO Pharma A/SAuthorised17/07/2017Psoriasis

FULL INTELLIGENCE ON BRODALUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →